Prudential Financial’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,920
Closed -$383K 2656
2021
Q2
$383K Buy
+13,920
New +$274K ﹤0.01% 2229

Prudential Financial's TBIO Position: Q3 2021 in Review

Prudential Financial sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 13,920 shares — an estimated $383K sold.

Prudential Financial first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $383K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Prudential Financial reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Prudential Financial sold 13,920 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $383K.
  • Prudential Financial first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Prudential Financial's Translate Bio, Inc. Common Stock position peaked at $383K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Prudential Financial's 13F filing for Q3 2021, filed 15 Nov 2021.